Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Thomas Balzer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Liver

Procedures

Intravenous Injections

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hammerstingl Renate; Huppertz Alexander; Breuer Josy; Balzer Thomas; Blakeborough Anthony; Carter Rick; Fusté Lluis Castells; Heinz-Peer Gertraud; Judmaier Werner; Laniado Michael; Manfredi Riccardo M; Mathieu Didier G; Müller Dieter; Mortelè Koenraad; Reimer Peter; Reiser Maximilian F; Robinson Philip J; Shamsi Kohkan; Strotzer Michael; Taupitz Matthias; Tombach Bernd; Valeri Gianluca; van Beers Bernhard E; Vogl Thomas J;
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
Knopp Michael V; Balzer Thomas; Esser Marc; Kashanian Franciska K; Paul Predip; Niendorf Hans P
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Halavaara Juha; Breuer Josy; Ayuso Carmen; Balzer Thomas; Bellin Marie-France; Blomqvist Lennart; Carter Rick; Grazioli Luigi; Hammerstingl Renate; Huppertz Alexander; Jung Gregor; Krause Denis; Laghi Andrea; Leen Edward; Lupatelli Luciano; Marsili Luca; Martin Julio; Pretorius E Scott; Reinhold Caroline; Stiskal Michael; Stolpen Alan H
Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Thomas Balzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Hammerstingl Renate; Huppertz Alexander; Breuer Josy; Balzer Thomas; Blakeborough Anthony; Carter Rick; Fusté Lluis Castells; Heinz-Peer Gertraud; Judmaier Werner; Laniado Michael; Manfredi Riccardo M; Mathieu Didier G; Müller Dieter; Mortelè Koenraad; Reimer Peter; Reiser Maximilian F; Robinson Philip J; Shamsi Kohkan; Strotzer Michael; Taupitz Matthias; Tombach Bernd; Valeri Gianluca; van Beers Bernhard E; Vogl Thomas J;
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
European radiology 2008;18(3):457-67.
2006: Knopp Michael V; Balzer Thomas; Esser Marc; Kashanian Franciska K; Paul Predip; Niendorf Hans P
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Investigative radiology 2006;41(6):491-9.
2006: Halavaara Juha; Breuer Josy; Ayuso Carmen; Balzer Thomas; Bellin Marie-France; Blomqvist Lennart; Carter Rick; Grazioli Luigi; Hammerstingl Renate; Huppertz Alexander; Jung Gregor; Krause Denis; Laghi Andrea; Leen Edward; Lupatelli Luciano; Marsili Luca; Martin Julio; Pretorius E Scott; Reinhold Caroline; Stiskal Michael; Stolpen Alan H
Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.
Journal of computer assisted tomography 2006;30(3):345-54.
2005: Bluemke David A; Sahani Dushyant; Amendola Marco; Balzer Thomas; Breuer Josy; Brown Jeffrey J; Casalino David D; Davis Peter L; Francis Isaac R; Krinsky Glenn; Lee Fred T; Lu David; Paulson Erik K; Schwartz Lawrence H; Siegelman Evan S; Small William C; Weber Therese M; Welber Adam; Shamsi Kohkan
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Radiology 2005;237(1):89-98.
2004: Huppertz Alexander; Balzer Thomas; Blakeborough Anthony; Breuer Josy; Giovagnoni Andrea; Heinz-Peer Gertraud; Laniado Michael; Manfredi Riccardo M; Mathieu Didier G; Mueller Dieter; Reimer Peter; Robinson Philip J; Strotzer Michael; Taupitz Matthias; Vogl Thomas J;
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Radiology 2004;230(1):266-75.
2003: Reimer Peter; Balzer Thomas
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.
European radiology 2003;13(6):1266-76.
2003: Vogl Thomas J; Schwarz Wolfram; Blume Stefan; Pietsch Michael; Shamsi Kohkan; Franz Martina; Lobeck Hartmut; Balzer Thomas; del Tredici Kelly; Neuhaus Peter; Felix Roland; Hammerstingl Renate M
Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
European radiology 2003;13(2):262-72.
2002: Reimer Peter; Müller Markus; Marx Christian; Balzer Thomas
Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver.
Academic radiology 2002;9 Suppl 2():S336-8.
2002: Hammerstingl Renate; Zangos Stephan; Schwarz Wolfram; Rosen Thomas; Bechstein Wolf-Otto; Balzer Thomas; Vogl Thomas J
Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient.
Academic radiology 2002;9 Suppl 1():S119-20.
2001: Zangos S; Hammerstingl R; Mack M G; Straub R; Engelmann K; Eichler K; Balzer T; Vogl T J
[Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2001;173(11):1034-40.
1999: Reimer P; Allkemper T; Matuszewski L; Balzer T
Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).
Journal of magnetic resonance imaging : JMRI 1999;10(1):65-71.
1998: Hammerstingl R; Vogl T J; Schwarz W; Kümmel S; Balzer T; Neuhaus P; Felix R
Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Academic radiology 1998;5 Suppl 1():S75-9; discussion S93-4.
1998: Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny E J; Shamsi K; Balzer T; Peters P E
[T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1998;168(3):228-36.
1998: Shamsi K; Balzer T; Saini S; Ros P R; Nelson R C; Carter E C; Tollerfield S; Niendorf H P
Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
Radiology 1998;206(2):365-71.
1997: Lemke A J; Sander B; Balzer T; Geens V; Hosten N; Felix R
[Safety and use of gadobutrol in patients with brain tumors (phase III trial)]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1997;167(6):591-8.
1997: Reimer P; Marx C; Rummeny E J; Müller M; Lentschig M; Balzer T; Dietl K H; Sulkowski U; Berns T; Shamsi K; Peters P E
SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison.
Journal of magnetic resonance imaging : JMRI 1997;7(6):945-9.
1997: Vogl T J; Schwarz W; Hammerstingl R; Kümmel S; Balzer J O; Mack M G; Diebold T; Balzer T; Shamsi K; Bechstein W O; Schrem H; Neuhaus P; Felix R
[Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1997;167(3):264-73.
1997: Kopp A F; Laniado M; Dammann F; Stern W; Grönewäller E; Balzer T; Schimpfky C; Claussen C D
MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
Radiology 1997;204(3):749-56.
1997: Reimer P; Allkemper T; Bremer C; Rummeny E J; Spiegel H U; Balzer T; Peters P E
Assessment of reperfusion injury by means of MR contrast agents in rat liver.
Journal of magnetic resonance imaging : JMRI 1997;7(3):490-4.
1997: Schmitz S A; Häberle J H; Balzer T; Shamsi K; Boese-Landgraf J; Wolf K J
Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Radiology 1997;202(2):399-405.
1997: Reimer P; Rummeny E J; Daldrup H E; Hesse T; Balzer T; Tombach B; Peters P E
Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
European radiology 1997;7(2):275-80.
1996: Vogl T J; Hammerstingl R; Schwarz W; Kümmel S; Müller P K; Balzer T; Lauten M J; Balzer J O; Mack M G; Schimpfky C; Schrem H; Bechstein W O; Neuhaus P; Felix R
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Investigative radiology 1996;31(11):696-708.
1996: Balzer T; Carter E C; Shamsi K; Niendorf H P
Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
Academic radiology 1996;3 Suppl 2():S417-9.
1996: Vogl T J; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller P K; Bechstein W O; Mack M G; Söllner O; Felix R
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Radiology 1996;200(1):59-67.
1996: Reimer P; Rummeny E J; Shamsi K; Balzer T; Daldrup H E; Tombach B; Hesse T; Berns T; Peters P E
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Radiology 1996;199(1):177-83.
1996: Reimer P; Tombach B; Daldrup H; Hesse T; Sander G; Balzer T; Shamsi K; Berns T; Rummeny E J; Peters P E
[New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)]
Der Radiologe 1996;36(2):124-33.
1995: Reimer P; Schuierer G; Balzer T; Peters P E
Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1995;34(5):694-7.
1995: Vogl T J; Friebe C E; Balzer T; Mack M G; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
[Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study]
Der Radiologe 1995;35(8):508-16.
1995: Daldrup H E; Reimer P; Rummeny E J; Tombach B; Berns T; Balzer T; Schimpfky C; Peters P E
[New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors]
Der Radiologe 1995;35(8):486-93.
1995: Reimer P; Rummeny E J; Daldrup H E; Balzer T; Tombach B; Berns T; Peters P E
Clinical results with Resovist: a phase 2 clinical trial.
Radiology 1995;195(2):489-96.
1991: Sandforth F; Witzel L; Balzer T; Gutschmidt S; Janicke I; Riecken E O
Identification of patients at high risk for colorectal carcinoma from biopsy studies of the apparently normal colorectal mucosa. A multivariate analysis.
European journal of clinical investigation 1991;21(3):295-302.
1988: Sandforth F; Heimpel S; Balzer T; Gutschmidt S; Riecken E O
Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis.
European journal of clinical investigation 1988;18(6):655-62.
1988: Balzer T; Sandforth F; Gutschmidt S; Riecken E O
Changes in the lectin-binding pattern of PNA-agglutinin and UEA1 during the DMH-induced carcinogenesis in the normal appearing colonic mucosa of the rat.
European journal of clinical investigation 1988;18(2):196-201.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Thomas Balzer

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Thomas Balzer (preview)

All Publications